Intravitreal Nesvacumab plus Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial

被引:0
|
作者
Boyer, David S. [1 ]
机构
[1] Retina Vitreous Assoc Med Grp, Ophthalmol, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3620
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab and/or intravitreal dexamethasone implant
    Herbaut, Antoine
    Knafo, Lise Qu
    Auregan, Audrey Giocanti
    Fajnkuchen, Franck
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [32] Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
    Justus G. Garweg
    Jana Štefanickova
    Carel Hoyng
    Tobias Niesen
    Thomas Schmelter
    Sergio Leal
    Sobha Sivaprasad
    Advances in Therapy, 2022, 39 : 2701 - 2716
  • [33] Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
    Garweg, Justus G.
    Stefanickova, Jana
    Hoyng, Carel
    Niesen, Tobias
    Schmelter, Thomas
    Leal, Sergio
    Sivaprasad, Sobha
    ADVANCES IN THERAPY, 2022, 39 (06) : 2701 - 2716
  • [34] Aflibercept for the treatment of diabetic macular edema
    Harkins, Keegan A.
    Haschke, Mary
    Do, Diana V.
    IMMUNOTHERAPY, 2016, 8 (05) : 503 - 510
  • [35] Morphological and functional changes in the macular area in diabetic macular edema after a single intravitreal injection of aflibercept
    Zhang, Chuan-He
    Gong, Bin
    Huang, Chao
    Shu, Xiang-Wen
    Chen, Tian-Yu
    Chen, Xuan
    Wu, Chang-Long
    Wang, Yu
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2023, 16 (01) : 88 - 94
  • [36] Morphological and functional changes in the macular area in diabetic macular edema after a single intravitreal injection of aflibercept
    Chuan-He Zhang
    Bin Gong
    Chao Huang
    Xiang-Wen Shu
    Tian-Yu Chen
    Xuan Chen
    Chang-Long Wu
    Yu Wang
    International Journal of Ophthalmology, 2023, 16 (01) : 88 - 94
  • [37] Intravitreal Ziv-Aflibercept for Diabetic Macular Edema: 48-Week Outcomes
    de Andrade, Gabriel Costa
    de Oliveira Dias, Joao Rafael
    Maia, Andre
    Farah, Michel Eid
    Meyer, Carsten H.
    Rodrigues, Eduardo Buchele
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (04): : 245 - 250
  • [38] Effects of Intravitreal Aflibercept on Retinal Function and Improvement of Macular Edema Associated With Diabetic Retinopathy
    Ichio, Atsushi
    Sugimoto, Masahiko
    Matsubara, Hisashi
    Mochida, Daiki
    Kato, Kumiko
    Kondo, Mineo
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (11): : 1 - 10
  • [39] Comparative study of intravitreal ranibizumab and aflibercept for diabetic macular edema with 'Treat and Extend' algorithm
    Chujo, Shinichiro
    Sugimoto, Masahiko
    Sasaki, Taku
    Ichio, Atsushi
    Miyata, Ryohei
    Matsubara, Hisashi
    Kondo, Mineo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [40] OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept
    Dastiridou, Anna
    Karathanou, Katerina
    Riga, Paraskevi
    Anagnostopoulou, Sofia
    Balasubramanian, Siva
    Mataftsi, Asimina
    Brazitikos, Periklis
    Ziakas, Nikolaos
    Androudi, Sofia
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (05) : 926 - 931